Hoth Therapeutics, Inc. (NASDAQ: HOTH)

Engel Law PLLC is investigating whether fair value to Hoth shareholders will result from the proposed merger between Hoth Therapeutics, Inc. (NASDAQ: HOTH) and Algorithm Sciences, Inc., pursuant to which current Hoth shareholders are expected to own approximately 14% of the combined company and current Algorithm shareholders are expected to own approximately 86% of the combined company.

The Firm’s investigation concerns:

(i) whether the Company’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction;
(ii) whether the merger consideration adequately compensates the Company’s shareholders; and
(iii) whether all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.

Join this Action

Hoth Therapeutics, Inc.

MM slash DD slash YYYY